会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS
    • 17BETA-HYDROXYSTERIDID DEHYDROGENASE抑制剂
    • WO2004085457A3
    • 2005-02-03
    • PCT/GB2004001234
    • 2004-03-22
    • STERIX LTDVICKER NIGELLAWRENCE HARSHANI RITHMA RUCHIALLAN GILLIAN MARGARETBUBERT CHRISTIANFISCHER DELPHINE SOPHIE MARIONPUROHIT ALANREED MICHAEL JOHNPOTTER BARRY VICTOR LLOYD
    • VICKER NIGELLAWRENCE HARSHANI RITHMA RUCHIALLAN GILLIAN MARGARETBUBERT CHRISTIANFISCHER DELPHINE SOPHIE MARIONPUROHIT ALANREED MICHAEL JOHNPOTTER BARRY VICTOR LLOYD
    • A61K31/56A61K31/566C07J20060101C07J41/00C07J71/00
    • C07J71/00C07J41/00
    • There is provided a compound of Formula (I) wherein (I) R is a selected from (i) an alkyloxyalkyl group (ii) a nitrile group, and wherein R is capable of forming a hydrogen bond (iii) alkylaryl group, wherein the aryl group is substituted by other than a C1-10 group (iv) alkenylaryl group wherein the aryl group is substituted (v) alkyiheteroaryl group, wherein when heteroaryl group comprises only C and N in the ring, the aryl group is substituted by other than a methyl group (vi) alkenylheteroaryl group, (vii) =N-O-alkyl or =N-O-H group (viii) branched alkenyl (ix) alkyl-alcohol group (x) amide or alkylamide wherein (a) the alkyl of the alkylamide is - CH2- or -CH2CH2-, (b) the amide is di-substituted and/or (c) the amide is substituted with at least one of a I kyl heterocycle group, al ke nyl heterocycle group, alkylheteroaryl group, alkenylheteroaryl group, heteroaryl group, alkylamine group, alkyloxyalkyl group, alkylaryl group, straight or branched alkyl group, (xi) -CHO so that R, together with R3 provide the enol tautomer (a); OR R1 together with R form (xii) a pyrazole wherein (a) R is =N-0-alkyl or =N-0-H group, (b) the pyrazole is substituted with one of alkyl-OH group, alkyl ester group, alkyloxyalkyl. group, branched alkyl group, and an amide and/or (c) the 2 position is substituted with a group selected from -OH and -0-hydrocarbyl (xiii) a heteroaryl ring to provide a compound of the formula (b); (II) R is selected from groups capable of forming a hydrogen bond, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group and a sulphonamide group; and (III) R is selected from -OH, =O, or a -C(=O)- mimetic.
    • 提供式(I)的化合物,其中(I)R 1选自(i)烷氧基烷基(ii)腈基,并且其中R 2能够形成氢键(iii )烷基芳基,其中芳基被除了其中芳基被取代的(C)芳基取代的(C 1 -C 6)烯基芳基以外的其它芳基取代;(ⅴ)芳基杂芳基,其中当杂芳基仅在环中仅包含C和N时,芳基 (vii)= NO-烷基或= NOH基(viii)支链烯基(ix)烷基醇基(x)酰胺或烷基酰胺,其中(a)烷基 的烷基酰胺是-CH 2 - 或-CH 2 CH 2 - ,(b)酰胺是二取代的,和/或(c)酰胺被I烷基杂环基,烯基杂环基,烷基杂芳基中的至少一个取代 ,烯基杂芳基,杂芳基,烷基胺基,烷氧基烷基,烷基芳基,直链或支链烷基,(xi)-CHO so t 与R 3一起提供烯醇互变异构体(a); 或R 1与R 3一起形成(xii)吡唑,其中(a)R 4是= N-O-烷基或= N-O-H基,(b)吡唑被烷基 - OH基,烷基酯基,烷氧基烷基。 基团,支链烷基和酰胺和/或(c)2位被选自-OH和-O-烃基(xiii)杂芳基环的基团取代,以提供式(b)的化合物; (II)R 2选自能够形成氢键的基团,氨基磺酸酯基团,膦酸酯基团,硫代膦酸酯基团,磺酸酯基团和磺酰胺基团; 和(III)R 3选自-OH,= O或-C(= O) - 模拟物。
    • 2. 发明申请
    • 2-SUBSTITUTED ESTROGEN SULPHAMATES FOR INHIBITION OF STEROID SULPHATASE
    • 2-取代的雌激素用于抑制甾体硫酸酯酶
    • WO2006032885A3
    • 2006-08-24
    • PCT/GB2005003641
    • 2005-09-21
    • STERIX LTDLEESE MATHEWPUROHIT ALANREED MICHAEL JOHNJOURDAN FABRICEPOTTER BARRY VICTOR LLOYDBURBERT CHRISTIAN
    • LEESE MATHEWPUROHIT ALANREED MICHAEL JOHNJOURDAN FABRICEPOTTER BARRY VICTOR LLOYDBURBERT CHRISTIAN
    • C07J41/00A61K31/565A61K31/566A61K31/57A61K31/58A61P5/32C07J3/00C07J7/00C07J31/00C07J43/00
    • C07J43/003C07J3/00C07J7/0005C07J31/006C07J41/0005C07J41/0072
    • The present invention provides a compound comprising a steroidal ring system and an optional group R 1 selected from any one of -OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the A ring of the steroidal ring system is optionally substituted at position 2 or 4 with a group R 4 which may be a suitable subtituent wherein the D ring of the steroidal ring system is substituted by a group R 2 of the formula -L-R 3 , wherein L is an optional linker group and R 3 is selected from groups which are or which comprise one of (i) -S0 2 R 5 , wherein R 5 is H, a hydrocarbyl group or a bond or group attached to the D ring; (ii) -NO 2 ; (iii) -SOR 6 , wherein R 6 is H or a hydrocarbyl group; (iv) -R 7 , wherein R 7 is a halogen; (v) - alkyl; (vi) -C(=O)R 8 , wherein R 8 is H or hydrocarbyl; (vii) -C=CR 9 , wherein R 9 is H or hydrocarbyl; (viii) -OC(=O)NR 10 R 11 wherein R 10 and R 11 are independently selected from H and hydrocarbyl; (ix), (x), (xi), (xii) and (xiii) are formulae wherein when R 3 is -alkyl, R 4 is present as a hydrocarbon group, when R 3 is -NO 2 R 4 is present and/or R 1 is present as a sulphamate group, and when R 3 is -C(=O)R 8 R 4 is present and R 1 is present as a sulphamate group.
    • 本发明提供了包含选自-OH,氨基磺酸酯基,膦酸酯基,硫代膦酸酯基,磺酸酯基或磺酰胺中的任何一种的甾体环系和任选的基团R 1的化合物 组; 其中所述甾族环系统的A环任选在位置2或4处被基团R 4取代,所述基团R 4可以是合适的取代基,其中所述甾族环系统的D环被基团R 其中L是任选的连接基团,R 3选自以下基团:其中R 1,R 2,R 3, (i)-S 0 2 R 5,其中R 5是H,连接到D环的烃基或键或基团; (ii)-NO 2 2; (iii)-SOR 6,其中R 6是H或烃基; (iv)-R 7,其中R 7为卤素; (ⅴ) - 烷基; (vi)-C(= O)R 8,其中R 8为H或烃基; (vii)-C = CR 9,其中R 9是H或烃基; (viii)-OC(= O)NR 10 R 11,其中R 10和R 11独立地选自 由H和烃基组成; (ix),(x),(xi),(xii)和(xiii)是其中当R 3为 - 烷基时,R 4为烃, 当R 3为-NO 2 R 4存在时,和/或R 1存在作为 并且当R 3为-C(= O)时,存在R 8 R 4和R 4,并且R 1〜 >作为氨基磺酸盐基团存在。